TransCode Therapeutics Inc (RNAZ) Stock Price, Quote, News & History

RNAZNASDAQ
$8.83
-0.77-7.97%
At close: Jul 10, 5:00 PM EST
$9.15
0.323.62%
After Hours: Jul 10, 7:00 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-21.40M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
22.67M
Free Cash Flow (TTM)
-21.40M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
1.27M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.49M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
7.27
Earnings Yield % (TTM)
-38.77%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.32

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$12.84M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$9.49
Close
$8.83
Volume / Avg.
59.60K / 58.14K
Day Range
$8.48 - $10.69
52 Wk Range
3.82 - 20.99
Market Cap
$8.70M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
64
Short Interest
5.56%
Days to Cover
2.59

About

Sector
Health Care
Industry
Biotechnology
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Pha...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy TransCode Therapeutics (RNAZ) stock?

A

You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.

View our list of the best stock brokerages

Q

Who are TransCode Therapeutics (RNAZ) competitors?

A

There are no as such competitors for TransCode Therapeutics.

Q

What is the forecast, or price target, for TransCode Therapeutics (RNAZ) stock?

A

TransCode Therapeutics has a consensus price target of $10.00.

Q

What is the current price for TransCode Therapeutics (RNAZ)?

A

The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $9.15 last updated July 10, 2026 at 7:00 AM EDT.

Q

Does TransCode Therapeutics (RNAZ) pay a dividend?

A

There are no upcoming dividends for TransCode Therapeutics.

Q

When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?

A

TransCode Therapeutics does not have any upcoming earnings scheduled.

Q

Is TransCode Therapeutics (RNAZ) going to split?

A

There is no upcoming split for TransCode Therapeutics.

Q

What sector and industry does TransCode Therapeutics (RNAZ) operate in?

A

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.